• Eur J Anaesthesiol · Nov 1995

    Randomized Controlled Trial Clinical Trial

    The effects of midazolam followed by administration of either vecuronium or atracurium on the QT interval in humans.

    • D G Michaloudis, F S Kanakoudis, A Xatzikraniotis, and T S Bischiniotis.
    • Department of Anaesthesia, University Hospital, Crete, Greece.
    • Eur J Anaesthesiol. 1995 Nov 1;12(6):577-83.

    AbstractProlongation of the QT interval may produce potentially hazardous dysrhythmias. The effects on the QT interval of midazolam followed by administration of either vecuronium or atracurium have been investigated. Thirty patients, ASA I or II, without cardiovascular problems, electrolyte abnormalities or receiving any medication were studied. All patients were premedicated with midazolam 0.08 mg kg-1 i.m. 30-60 min before surgery. Anaesthesia was induced with midazolam 0.4 mg kg-1. ECG recordings as well as heart rate and arterial pressure measurements were obtained before induction of anaesthesia and 1, 3 and 5 min after midazolam administration. Further recordings were obtained at 1, 3 and 5 min after either vecuronium 0.1 mg kg-1 (15 patients) or atracurium 0.5 mg kg-1 (15 patients). Further recordings were obtained immediately after tracheal intubation and at 1, 3 and 5 min later. Midazolam followed by administration of either vecuronium or atracurium did not produce any significant change in QTc interval (QT interval corrected for heart rate). Statistically significant prolongation of QTc was observed in both groups after intubation, although the mean QTc values did not exceed the upper limits of normal. Heart rate and arterial pressure were also increased significantly in both groups after intubation.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.